Clinical trial reportInvestigational new drugsPublished
A phase 1b open-label study to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of py314 in combination with pembrolizumab in patients with advanced renal cell carcinoma
Regional connection
Verified An author affiliation on the Europe PMC record names Thomas Jefferson University. Affiliation source
- Institution
- Thomas Jefferson University
- County
- Philadelphia County
Publication record
- Type
- Clinical trial report
- Venue
- Investigational new drugs
- Published
- Topic
- Clinical care
- Subject terms
- Humans; Carcinoma, Renal Cell; Kidney Neoplasms; Neoplasm Recurrence, Local; Aged; Female; Male; Tumor Microenvironment; Antibodies, Monoclonal, Humanized; Macrophage; Immunotherapy; Renal cell carcinoma
- PubMed ID
- 38372949
- Added to directory
- Source checked